Who invested in Acrigen Biosciences

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.0Mraised across 1 round since 2022, from 1 source

Latest round: Grant, $1.0MFeb 2022
Investors: 3

See who backed them

The rounds

Feb 2022
Grant$1.0M
Source recorded

Founders and team

From the SEC filings it signed: 1 on the team.

David RabukaExecutive Officer, Director, Promoteri

On the board, as filediJoseph Bondy-DenomyKaren Boezi

Everyone who backed them

National Science FoundationGovernment1round

Alexandria Venture InvestmentsVC firm1round

Catalyst FundGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acrigen Biosciences

Who invested in Acrigen Biosciences?

Acrigen Biosciences's investors include National Science Foundation, Alexandria Venture Investments and Catalyst Fund.

How much has Acrigen Biosciences raised?

Acrigen Biosciences has raised $1.0M across 1 round since 2022.

When did Acrigen Biosciences last raise?

Acrigen Biosciences's most recent round was a Grant of $1.0M in Feb 2022.

What was Acrigen Biosciences's biggest round?

Its most recent round, $1.0M in Feb 2022, is also its largest on record.

Who backed Acrigen Biosciences first?

Acrigen Biosciences's first round on record, in Feb 2022, was backed by National Science Foundation, Alexandria Venture Investments and Catalyst Fund.